Oramed Pharmaceuticals
ORMP on XNAS, Oramed Pharmaceuticals Inc.
Measures activity, not value. Not investment advice.
New positions, last 12 months
69
+331% vs the 12 months before
Positions closed, last 12 months
28
0% vs the 12 months before
Net, last 12 months
+41
new positions minus positions closed
Sharp changes
2
many funds opening a new position
What usually follows Change in institutional holders was not followed by a clear share-price difference over the next 6 months. No relationship found How we measured it
Largest holders over the last 8 quarters
Shares reported on Form 13F at each quarter end; the 10 largest holders of Q3 2026. "–": no full report for that quarter (not filed yet, or positions kept confidential)| Institution | Trend | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Mercer Global Advisors Inc | 0 | 0 | 0 | 0 | 0 | 1.9M | 3.8M | 3.8M | |
| Aquamarine Financial (Cayman) Ltd | – | – | – | 2.0M | 2.0M | 2.1M | 2.5M | 2.7M | |
| Murchinson Ltd. | 1.8M | 1.8M | 1.8M | 1.8M | 1.3M | 1.3M | 1.3M | 2.1M | |
| Gem Investment Advisors, LLC | – | – | – | – | 2.0M | 1.6M | 2.0M | 2.0M | |
| BlackRock, Inc. | 94K | 92K | 86K | 110K | 90K | 92K | 1.6M | 1.8M | |
| BML Capital Management, LLC | 2.6M | 3.0M | 3.1M | 3.2M | 3.2M | 3.2M | 866K | 884K | |
| Boothbay Fund Management, LLC | 845K | 845K | 845K | 845K | 612K | 601K | 579K | 821K | |
| Geode Capital Management, LLC | 25K | 25K | 24K | 24K | 24K | 24K | 501K | 501K | |
| State Street Corp | 61K | 65K | 66K | 0 | 0 | 0 | 242K | 467K | |
| Renaissance Technologies LLC | 152K | 142K | 144K | 149K | 148K | 148K | 184K | 294K |
Form 13F holdings by quarter end.
See the numbers
| Quarter of Jul 2026: new positions 16, positions closed 9 |
| Quarter of Apr 2026: new positions 28, positions closed 8 |
| Quarter of Jan 2026: new positions 15, positions closed 7 |
| Quarter of Oct 2025: new positions 10, positions closed 4 |
| Quarter of Jul 2025: new positions 4, positions closed 5 |
| Quarter of Apr 2025: new positions 3, positions closed 7 |
| Quarter of Jan 2025: new positions 4, positions closed 9 |
| Quarter of Oct 2024: new positions 5, positions closed 7 |
| Quarter of Jul 2024: new positions 7, positions closed 10 |
| Quarter of Apr 2024: new positions 7, positions closed 1 |
| Quarter of Jan 2024: new positions 6, positions closed 13 |
| Quarter of Oct 2023: new positions 7, positions closed 7 |
| Quarter of Jul 2023: new positions 13, positions closed 6 |
| Quarter of Apr 2023: new positions 10, positions closed 19 |
| Quarter of Jan 2023: new positions 11, positions closed 27 |
| Quarter of Oct 2022: new positions 17, positions closed 10 |
| Quarter of Jul 2022: new positions 5, positions closed 15 |
| Quarter of Apr 2022: new positions 17, positions closed 28 |
| Quarter of Jan 2022: new positions 10, positions closed 19 |
| Quarter of Oct 2021: new positions 27, positions closed 14 |
| Quarter of Jul 2021: new positions 26, positions closed 6 |
| Quarter of Apr 2021: new positions 34, positions closed 9 |
| Quarter of Jan 2021: new positions 15, positions closed 7 |
| Quarter of Oct 2020: new positions 10, positions closed 7 |
| Quarter of Jul 2020: new positions 6, positions closed 5 |
| Quarter of Apr 2020: new positions 5, positions closed 3 |
| Quarter of Jan 2020: new positions 6, positions closed 4 |
| Quarter of Oct 2019: new positions 3, positions closed 4 |
| Quarter of Jul 2019: new positions 4, positions closed 2 |
| Quarter of Apr 2019: new positions 3, positions closed 2 |
| Quarter of Jan 2019: new positions 3, positions closed 5 |
| Quarter of Oct 2018: new positions 3, positions closed 4 |
| Quarter of Jul 2018: new positions 7, positions closed 1 |
| Quarter of Apr 2018: new positions 3, positions closed 2 |
| Quarter of Jan 2018: new positions 2, positions closed 6 |
| Quarter of Oct 2017: new positions 1, positions closed 1 |
| Quarter of Jul 2017: new positions 1, positions closed 2 |
| Quarter of Apr 2017: new positions 3, positions closed 2 |
| Quarter of Jan 2017: new positions 0, positions closed 3 |
| Quarter of Oct 2016: new positions 2, positions closed 2 |
What the numbers say
- New positions: 16 vs positions closed: 9 in the quarter from 1 Jul 2026.
- Net new institutional positions over 12 months: 41, number 242 of 820 Health Care companies with data (median 14).
- 2 sharp changes in all loaded history (many funds opening a new position).
- 13F moves in the last four quarters: the largest is added, 83 (35%).
See the numbers
| Added | 83 (35%) |
| Opened | 69 (29%) |
| Cut | 60 (25%) |
| Closed | 28 (12%) |
Every measure from this source
5 years, by the period each figure describes
Sharp changes
2 in all loaded history, strongest first
Oramed Pharmaceuticals saw 35 13F filers open a new position in the quarter ended 30 Jun 2021, 7.0× the same quarter last year.
Same quarter last year: 5; its normal quarter is 5.5.
See the evidence
- This period
- 35 (the quarter ended 30 Jun 2021)
- Normal quarter (median of 8 earlier)
- 5.5
- Typical spread (median absolute deviation)
- 2
- How far from its usual level
- +9.8
- Same quarter last year
- 5
- History used
- 2,830 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Check it at the source: SEC Form 13F data sets.
Oramed Pharmaceuticals saw 27 13F filers open a new position in the quarter ended 30 Sep 2021, 4.5× the same quarter last year.
Same quarter last year: 6; its normal quarter is 6.5.
See the evidence
- This period
- 27 (the quarter ended 30 Sep 2021)
- Normal quarter (median of 8 earlier)
- 6.5
- Typical spread (median absolute deviation)
- 3
- How far from its usual level
- +4.6
- Same quarter last year
- 6
- History used
- 2,922 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Check it at the source: SEC Form 13F data sets.
The records
Newest first, by the day each became public